4Tsai H C, Kuo P H,Yang P C. Fever,consciousness disturbance,and muscle rigidity in a 68-year-old man with depressive disorder [ J ]. Chest, 2003,124 ( 4 ) : 1598-1601.
5Montoya A, Ocampo M, Torres-Ruiz A. Neuroleptic malignant syndrome in Mexico [ J ]. Can J Clin Pharmacol, 2003,10(3) :111-113.
6Mizuno Y, Takubo H, Mizuta E, et al. Malignant syndrome in Parkinson's disease: concept and review of the literature[ J ]. Parkinsonism Relat Disord ,2003,9 ( suppl 1 ) : 3-9.
7Kawanishi C. Genetic predisposition to neuroleptic malignant syndrome: implications for antipsychotic therapy [ J ]. Am J Pharmacogenomics, 2003,3 ( 2 ) : 89-95.
8Delay J,Pichot P,Lemperiere T,et al.Un neuroleptique majeurnon-phenothiazine et non reser pinique,I'haloperidol dans letraitmement des psychoses.Annales Medico-Psychologique,1960,118:145-152.
9Rosebush PI,Stewart T,MazurekMF.The treatment of neuroleptic malignant syndrome.Are dantr olene and br omocri p tine useful adjuncts to supportive care Br J Psychiat,1991,159(11):709-712.
10Marcos S.Neurolep tic malignant syndrome-like,or-dopaminergic malignant syndrome-due to levodopa therapy withdrawal.Clinical features in 11 patients.Parkins onism and Related Dis orders,2003,9(3):175-178.
